Related Experiment Video
Updated: Jan 8, 2026
08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
18.0K
MicroRNA Crossroads in PCOS and Endometriosis
Girrijha Sambath1, Januki Kalai1, Usha Rani G2
1Department of Biomedical Sciences, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Reproductive Sciences (Thousand Oaks, Calif.)
|December 23, 2025
Summary
Polycystic Ovary Syndrome (PCOS) and endometriosis share links. MicroRNAs are key regulators in these gynecological disorders, offering potential diagnostic and therapeutic targets for women's health.
Area of Science:
- Gynecology
- Endocrinology
- Molecular Biology
Background:
- Polycystic Ovary Syndrome (PCOS) and endometriosis are prevalent gynecological disorders with unknown etiologies.
- Both conditions share overlapping symptoms, genetic factors, and regulatory pathways.
- Understanding their links may advance diagnostics and therapeutics for women's reproductive health.
Purpose of the Study:
- To review the role of microRNAs in PCOS and endometriosis.
- To explore microRNAs as potential diagnostic and therapeutic markers for these gynecological disorders.
Main Methods:
- Comprehensive literature review focusing on microRNA involvement in PCOS and endometriosis.
- Analysis of microRNA's regulatory functions in gene expression and post-transcriptional modifications.
- Examination of microRNA's impact on the Hypothalamic-Pituitary-Ovarian axis and related pathways.
Main Results:
- MicroRNAs are crucial regulators of gene expression impacting pathways related to inflammation, immunity, metabolism, and neuroendocrine function.
- MicroRNAs are significantly associated with the pathophysiology and clinical manifestations of PCOS and endometriosis.
- Evidence suggests microRNAs play a role in the shared genetic and epigenetic factors of these conditions.
Conclusions:
- MicroRNAs demonstrate multifaceted roles in gynecological disorders like PCOS and endometriosis.
- MicroRNAs hold promise as novel diagnostic and therapeutic targets for improving women's health outcomes.
- Further research into microRNA applications could revolutionize the management of gynecological conditions.
Related Concept Videos
01:22MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
01:22MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
02:57piRNA - Piwi-interacting RNAs
7.4K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K
02:07Oogenesis
68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
01:23RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K